Tocainide
Tocainide is an analogue of lidocaine that undergoes negligible hepatic first-pass metabolism and therefore approaches 100 per cent oral bioavailability. It is effective for ventricular tachyarrhythmias, but its efficacy appears to be less than that of lidocaine. The effect of lidocaine on an arrhythmia may predict the efficacy of tocainide on that arrhythmia.
- PATHOPHYSIOLOGY
- APPROACH TO THE DIAGNOSIS OF JAUNDICE
- DEFINITION
- APPROACH TO THE PATIENT WITH SUSPECTED OR CONFIRMED ARRHYTHMIAS
- DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
- BENIGN NEOPLASMS
- Pathology
- RENAL PHARMACOLOGY
- EFFECTORS OF THE RESPIRATORY SYSTEM
- Clinical Course, Pathogenesis, and Anatomy of Acute Tubular Necrosis
- Nephrosclerosis
- SCREENING TESTS OF HEPATOBILIARY DISEASE
- Conservative Management
- CLASSIFICATION AND PATHOPHYSIOLOGY
- DRUG-ASSOCIATED RENAL INJURY
- ANGINA PECTORIS
- TREATMENT
- ORIGIN OF ABDOMINAL PAIN
- Endocrine and Other Considerations
- OBSTRUCTIVE LUNG DISEASE
- Clinical Presentation
- CLINICAL MANIFESTATIONS OF GALLSTONES
- CARDIAC DEVELOPMENT
- OTHER ESOPHAGEAL DISORDERS
- CARDIOVASCULAR RESPONSE TO EXERCISE
- CONTROL OF BREATHING IN DISEASE STATES
- MOTOR DISORDERS OF THE ESOPHAGUS
- Other Clearly Extrinsic Causes of Diffuse Infiltrative Lung Disease
- PROGNOSIS
- ACID-PEPTIC DISEASE
- Bartter’s Syndrome
- CHIP Perinatal Coverage
- Chronic Interstitial Nephritis
- Magnetic Resonance Imaging (MRI)
- Management